Tirzepatide: A Review in Type 2 Diabetes

2024/02/01 by Nicole L. France, Yahiya Y. Syed · 25 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Diabetes Treatment and Management #Pharmacology and Obesity Treatment #Metabolism, Diabetes, and Cancer

paper · doi:10.1007/s40265-023-01992-4

Cited by

• Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
• The Pharmacological Landscape for Fatty Change of the Pancreas. [europepmc]
• Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now? [europepmc]
• Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. [europepmc]
• Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care. [europepmc]
• Focus on Glucagon-like Peptide-1 Target: Drugs Approved or Designed to Treat Obesity. [europepmc]
• Advances in Oral Biomacromolecule Therapies for Metabolic Diseases. [europepmc]
• Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. [europepmc]
• Polypharmacology: new drugs in 2023-2024. [europepmc]
• Tirzepatide Was Associated with Improved Health-Related Quality of Life in Adults with Obesity or Overweight and Type 2 Diabetes: Results from the Phase 3 SURMOUNT-2 Trial. [europepmc]
• Metabolic rewiring and inter-organ crosstalk in diabetic HFpEF. [europepmc]
• Tirzepatide vs semaglutide and liraglutide for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States. [europepmc]
• Therapeutic peptides: chemical strategies fortify peptides for enhanced disease treatment efficacy. [europepmc]
• Exploring the Protective Effects of Traditional Antidiabetic Medications and Novel Antihyperglycemic Agents in Diabetic Rodent Models. [europepmc]
• Metabolic breakdown: Linking insulin resistance and mitochondrial dysfunction to neurodegeneration in Alzheimer's disease. [europepmc]
• Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis. [europepmc]
• Effect of tirzepatide treatment on patient-reported outcomes among SURMOUNT-OSA participants with obstructive sleep apnea and obesity. [europepmc]
• How Glucagon-Like Peptide-1 Medications Are Depicted in Instagram Posts Regarding Women's Health, Nontraditional Access, and Barriers to Access: Content Analysis. [europepmc]
• Organoids: their emerging essential role in pathological mechanisms and drug discovery of diabetes and its complications. [europepmc]
• Intractable Vomiting in the Setting of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist and Cannabis Usage. [europepmc]
• Progress in peptide and protein therapeutics: Challenges and strategies. [europepmc]
• A narrative review on tirzepatide's therapeutic potential in glycemic control and cardioprotection. [europepmc]
• The promoting roles of GLP1R and GIPR in stemness maintenance and multiple lineage-specific differentiation of PDLSCs. [europepmc]
• Treatment of the disease of obesity in patients with type 1 diabetes with tirzepatide: a protocol for a randomised controlled trial in a single-centre setting. [europepmc]
• GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives. [europepmc]